Aurobindo Pharma reported INR10.96B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Cipla INR 3.82B 840.2M Mar/2026
Divis Laboratories Ltd INR 50M 30M Mar/2026
Dr.Reddys Laboratories INR 12.2B 595M Mar/2026
Hindustan Unilever INR 11.04B 2.59B Mar/2026
Sun Pharmaceuticals INR 3.93B 309.9M Mar/2026
UPL INR 165.56B 16.81B Mar/2026